Intraarterial chemotherapy in Uni-asia Cancer hospital

Intraarterial chemotherapy at UNI-ASIA Cancer Hospital in Chengdu, China, is a targeted interventional treatment for unresectable solid tumors. This procedure delivers medication directly to the tumor site, creating a drug concentration dozens of times higher than standard intravenous methods. The hospital is a specialized oncology center featuring 600 beds and a multidisciplinary team approach for complex cases.

Advanced Interventional Expertise

The oncology department is led by highly experienced specialists with international training. Prof. Dr. Liao Zhengyin is a senior scholar from Johns Hopkins Hospital who has performed 40,000+ interventional procedures. Prof. Dr. Zhang Jinshan, who holds a Ph.D. from Nagasaki University, pioneered specific embolization techniques for liver cancer. The team also includes Dr. Wu Chaobo, who has performed 10,000+ procedures and gained experience at a JCI-accredited facility in the US.

The TAI Procedure Method

The hospital uses Transarterial Infusion (TAI) to treat hypervascular tumors. Doctors perform the treatment in a specialized suite using digital subtraction angiography for real-time guidance. This imaging allows the specialist to move a thin catheter through the arteries with millimeter precision.

• Small access point: The doctor makes a tiny needle hole in the femoral artery at the groin.
• Local anesthesia: Only the puncture site is numbed, so the patient remains awake.
• Short duration: The entire process typically takes less than one hour.
• High concentration: Medication goes directly into the tumor, sparing healthy organs from high doses.

Recovery and Treatment Goals

Because the procedure is minimally invasive, recovery is fast. Patients usually get out of bed and walk the day after the intervention. Most people return to their normal daily activities shortly after leaving the hospital. While every case varies, patients often undergo 2 to 4 sessions to achieve visible tumor shrinkage. This method is especially helpful for patients with hepatocellular carcinoma who cannot have traditional surgery. To learn more about treatment options at UNI-ASIA Cancer Hospital, you can leave a request on Bookimed.